logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Does the handbook go too far?

27 May 2014

The EFA has reportedly demanded that an academy sponsor terminates its contract with a leisure facilities management company (owned by the principal of the academy) due to the ‘risk of a conflict of interest’. Company and charity law requires directors to avoid conflicts of interests and declare interests in proposed transactions or arrangements. Whilst many think the law provides sufficient protection, the Academies’ Financial Handbook goes further.

The handbook states that an academy trust must pay no more than ‘cost’ for goods or services provided by any organisation connected to a director. The term ‘connected to’ captures entities owned, or even part-owned, by a director. Trustees of an academy need to be careful before entering into any contracts that might be caught by this provision in the handbook, as such contracts could be set aside regardless of whether the supplier provides best value for money or is deemed to be the highest quality provider and regardless of whether procedures to deal with conflicts have been followed.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up